Skip to main content
OpenTrials

Clinical trial condition

Arbovirus Infections

Explore clinical trials studying Arbovirus Infections. Study availability and eligibility vary by location and protocol.

474 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Arbovirus Infections trial results

Active, not recruiting

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

NCT06579755

Conditions
Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations
  • Fundacion Huesped - PPDS Buenos Aires, Argentina
  • Associacao Obras Sociais Irma Dulce Hospital Santo Antonio Salvador, Estado de Bahia, Brazil
  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS São José do Rio Preto, São Paulo, Brazil
  • Singapore General Hospital (SGH) Singapore
View Trial Details
Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA

NCT04942210

Conditions
Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations
  • Emory University Decatur- Site Number : 8400005 Decatur, Georgia, United States
  • Velocity Clinical Research- New Orleans Site Number : 8400008 New Orleans, Louisiana, United States
  • Johns Hopkins Bloomberg School of Public Health (JHSPH)- Site Number : 8400004 Baltimore, Maryland, United States
  • Harvard University Medical School- Site Number : 8400002 Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination

NCT06007183

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Alliance for Multispecialty Research, LLC Mobile, Alabama, United States
  • Alliance for Multispecialty Research, LLC Tempe, Arizona, United States
  • Optimal Research, LLC Melbourne, Florida, United States
  • Suncoast Research Associates, LLC Miami, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07254702

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras Belo Horizonte, Minas Gerais, Brazil
  • Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus Laranjeiras, Sergipe, Brazil
  • Fundação Faculdade Regional De Medicina De São José Do Rio Preto São Pedro, São Paulo, Brazil
View Trial Details
Active, not recruiting

A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

NCT07047521

Conditions
Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations
  • Paratus Clinical Research Western Sydney Blacktown, New South Wales, Australia
  • Emeritus Research Sydney Botany, New South Wales, Australia
  • Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
  • Veritus Research Bayswater, Victoria, Australia
View Trial Details
Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

NCT04838444

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Accelerated Enrollment Solutions (AES) Phoenix, Arizona, United States
  • Velocity Clinical Research Hallandale, Florida, United States
  • Accelerated Enrollment Solutions (AES) Chicago, Illinois, United States
  • Alliance for Multispecialty Research (AMR) Lexington, Kentucky, United States
View Trial Details
Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

NCT05011123

Conditions
Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations
  • Investigational Site Number : 2460001 Helsinki, Finland
  • Investigational Site Number : 2460002 Tampere, Finland
  • Investigational Site Number : 2460003 Turku, Finland
  • Investigational Site Number : 2500008 Lyon, France
View all 23 locations
View Trial Details

Related conditions